Previous 10 | Next 10 |
Massachusetts-based healthcare provider Enthea has revealed that it is now offering psychedelic-assisted therapy coverage in employee healthcare plans nationwide . The provider was in the news last year when soap company Dr. Bronners announced that it would be offering psychedelic-assisted the...
2023-09-26 13:17:43 ET More on psychedelic drug development Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets. COMPASS: The Landscape Is Changing Qui...
This June, America’s first-ever service center for psilocybin-assisted therapy opened in Oregon, marking both the state and country’s first definitive steps toward legalizing therapeutic psilocybin for the masses. Oregon is the first state in the country to offer psilocybin-rela...
2023-09-19 08:00:18 ET FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – September 19, 2023 – Depression is costing the economy $1 trillion in lost production every single year. Yet, a classical compound that even the FDA has twi...
2023-09-16 16:00:56 ET On Sept. 14, the Multidisciplinary Association for Psychedelic Studies ("MAPS") announced positive results on a second phase 3 trial for MDMA -- also known as ecstasy -- for post-traumatic stress disorder that were published in a scientific journal. The data in th...
Recent research investigating the interaction between psychedelics and opioids has found that using the two together to treat chronic pain may not be a good idea. Opioids have been the go-to treatment for pain disorders for a long time, but they have lost popularity over the past decade, especi...
NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conferenc...
California Assembly members have approved a psychedelic legalization measure passed by the Senate before sending it back to the Senate for discussions on recent amendments. The bill could potentially land on Governor Gavin Newsom’s desk once it advances through the Senate, putting Califo...
Even though psychedelics have been illegal since the 1970s, psychedelic use among people has surged in recent years , partly due to claims of psychedelics’ therapeutic properties and the fact that younger generations are increasingly moving away from alcohol and tobacco. For people look...
2023-09-01 19:02:09 ET Summary Atai Life Sciences is advancing RL-007 for the treatment of cognitive impairment associated with schizophrenia, with top-line results expected in the 2nd half of 2024. The company is also working on advancing COMP360 for treatment-resistant depressio...
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Alcohol use disorder is a disorder characterized by an inability to stop or control one’s drinking despite adverse health, occupational or social consequences. Conventional treatments include medication, behavioral therapy, and support groups. Even with these treatments, however, many ind...
Psychedelics such as DMT, LSD and psilocybin have demonstrated promise in the treatment of affective symptoms of a range of disorders. These drugs work by inducing an altered state of consciousness , which includes intensified perceptions and emotions, which have been associated with therapeutic...